Phathom Pharmaceuticals Inc. logo

Phathom Pharmaceuticals Inc.

PHAT | NASDAQ
Chart Builder DCF Calculator
$7.45
-$0.03 (-0.40%)
At close: Sep 21, 2026, 4:00 PM ET
$7.45
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$605.14M
Enterprise Value
$422.76M
Beta
0.51
Average Volume
1.3M
Shares Outstanding (Diluted)
83.75M
Shares Change YoY
15.57%
Institutional Ownership
83.96%
Exchange
NASDAQ
ISIN
US71722W1071

Price Performance

Price Change 1M
-16.1%
Price Change 3M
-31.4%
Price Change 6M
-28.8%
Price Change YTD
-52.6%
Price Change 1Y
-36.5%
Price Change 3Y
-29.9%
Price Change 5Y
-76.6%
1M CAGR (ann.)
-10.8%
1Y CAGR (ann.)
-32.0%
5Y CAGR (ann.)
-25.9%
All-Time CAGR
-15.8%

Valuation

PE Ratio
-5.82
Forward PE
10.61
PEG Ratio
-0.04
Forward PEG
0.03
PS Ratio
2.51
Forward PS
1.20
PB Ratio
-1.75
P/FCF Ratio
-16.49
P/Adj. FCF Ratio
-9.46
P/OCF Ratio
-16.93
EV/Sales
1.76
EV/EBIT
-12.75
EV/EBITDA
-11.51
EV/FCF
-11.57
Earnings Yield
-17.2%
FCF Yield
-6.1%
Adj. FCF Yield
-10.6%

Financial Health

Net Cash
$179.95M
Total Debt
$2.53M
Cash & Short-Term Investments
$182.48M
Total Assets
$327.08M
Current Ratio
1.92
Quick Ratio
1.87
Debt / Equity Ratio
-0.49
Debt / EBITDA
-0.07
Debt / FCF
-0.07
OCF / Debt
-14.53
Interest Coverage
-0.64
Altman Z-Score
-5.10
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
82.9%
Operating Profit Margin
-17.0%
EBITDA Margin
-14.7%
Net Profit Margin
-41.3%
FCF Margin
-15.3%
Adj. FCF Margin
-26.6%
SBC / Revenue
11.3%
SBC Impact (per share)
-74.3%

Returns

Return on Assets
-30.3%
Return on Equity
25.7%
Return on Invested Capital
-23.4%
Return on Capital Employed
-23.4%
Return on Tangible Assets
-30.3%

Historical Growth (CAGR)

Revenue CAGR 3Y
94.8%
Revenue CAGR 5Y
81.6%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
51.8%
EPS CAGR 5Y
15.5%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
51.2%
FCF CAGR 5Y
4.6%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
9
EPS Growth Next 3Y
117.7%
Revenue Growth Next 3Y
51.9%
Earnings Date
Oct 28, 2026
EPS Estimate (next Q)
$0.07
EPS Growth Est (next Q)
-117.1%
Revenue Est (next Q)
$85.38M
Revenue Growth Est (next Q)
72.5%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$17.60
Price Target Upside
136.2%

Cash Flow

Operating Cash Flow
$-36.69M
Free Cash Flow
$-36.54M
Adj. Free Cash Flow
$-63.7M
FCF Per Share
-$0.44
OCF Per Share
-$0.44
OCF/S Ratio
-15.3%

Income Statement

Revenue
$239.66M
Gross Profit
$198.73M
Operating Income
$-40.64M
EBITDA
$-36.74M
Net Income
$-81.49M
EPS (Diluted)
-$1.28
Revenue / Employee
$645.99K
Profit / Employee
$-219.65K
Employees
371

© 2026 bestshares.com. All rights reserved.